In disease management trials the typical phase I, II, and III approaches are applied but this is cumbersome and often illogical as these phases were developed to facilitate new drug and vaccine registration trials.
These phases often overlap with each other and vary in length depending on the game design.
These phases often operate independently; interact in nonlinear ways; and vary demographically, geographically and through time.
However, these phases often overlap during the disease course [ 1].
However, it is important to understand that these phases often exist simultaneously in phosphated zeolites.
These phases, often (questionably) considered as preprocessing and postprocessing phases, may result to be as expensive as the simulation itself.
Classical descriptions of ARDS, based on lung biopsy and postmortem specimens, have artificially divided the condition into three phases – exudative, proliferative and fibrotic [ 10] – although in practice these phases often overlap [ 1].
These phases are often neglected in papers on sparse direct factorization but, in many applications, they can be the bottleneck so it is crucial to implement them efficiently.
Their accounts revealed that moving through these phases was often difficult, largely because of a perceived lack support from the health care system.
However, these phases are often described as nonexclusive; individuals may shift to a phase of enacting self-management behaviors but later shift back to a phase of considering and planning for self-management, and at times, individuals can engage in several phases at the same time (e.g., managing to change their diet but being unable to stop smoking) [ 35].
